The Skin Care Products for Acne Prone segmentation by application distinguishes three primary usage contexts: Topical Treatment, Oral Medication, and Professional Procedure. Topical Treatment, encompassing gels, creams, and serums applied directly to the skin, commands the largest share—approximately 55 % of total market revenue—driven by consumer preference for over‑the‑counter solutions and the breadth of active ingredients such as benzoyl peroxide and salicylic acid. Oral Medication, which includes systemic antibiotics, hormonal modulators, and isotretinoin, accounts for roughly 30 % of the market; its contribution is amplified by dermatologists’ prescriptions for moderate to severe acne where topical agents alone are insufficient. Professional Procedure covers in‑office interventions like chemical peels, laser therapy, and photodynamic treatments, representing the remaining 15 % of sales; this segment’s growth is linked to higher per‑procedure pricing and increasing patient willingness to invest in clinically supervised outcomes. Collectively, these application categories form the backbone of the market taxonomy, each adding distinct value through differing distribution channels, price points, and efficacy profiles.